ABSTRACT Obesity, insulin resistance (IR), and the gut microbiome intricately interplay in
Metabolic-associated Steatotic Liver Disease (MASLD), previously known as Non-Alcoholic …

It is now well established that gut flora and chronic liver diseases are closely interrelated.
This association is most evident at late stages of the disease: cirrhosis and impaired liver …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. NAFLD begins as a relatively benign hepatic steatosis which can evolve to non …

The complex interplay between the gut microbiota, the intestinal barrier, the immune system
and the liver is strongly influenced by environmental and genetic factors that can disrupt the …

Background Non-alcoholic fatty liver (NAFLD) is a common, multi-factorial, and poorly
understood liver disease whose incidence is globally rising. NAFLD is generally …

Metabolism-associated fatty liver disease (MAFLD) is a multifaceted disease that involves
complex interactions between various organs, including the gut and heart. It is defined by …

Non-alcoholic fatty liver disease (NAFLD) has emerged as a major health problem
worldwide. Whereas overnutrition and obesity are crucially involved in the development of a …

Introduction Metabolic-associated liver diseases have emerged pandemically across the
globe and are clinically related to metabolic disorders such as obesity and type 2 diabetes …

Non-alcoholic fatty liver disease (NAFLD) has emerged as one of the leading liver diseases
worldwide. NAFLD is characterized by hepatic steatosis and may progress to an …

Nonalcoholic fatty liver disease (NAFLD) is widely emerging as the most prevalent liver
disorder and is associated with increased risk of liver-related and cardiovascular mortality …